Ulisse Biomed S.p.A. (BIT:UBM)
Italy flag Italy · Delayed Price · Currency is EUR
1.020
+0.020 (2.00%)
Nov 3, 2025, 2:38 PM CET

Ulisse Biomed Revenue

Ulisse Biomed had revenue of 528.79K EUR in the half year ending June 30, 2025, with 3,176.49% growth. This brings the company's revenue in the last twelve months to 925.87K, up 119.96% year-over-year. In the year 2024, Ulisse Biomed had annual revenue of 767.93K with 1,059.87% growth.

Revenue (ttm)
925.87K
Revenue Growth
+119.96%
P/S Ratio
26.84
Revenue / Employee
51.44K
Employees
22
Market Cap
24.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024767.93K701.72K1,059.87%
Dec 31, 202366.21K-72.23K-52.17%
Dec 31, 2022138.44K-142.00K-50.64%
Dec 31, 2021280.44K-325.06K-53.68%
Dec 31, 2020605.50K594.63K5,469.84%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Recordati Industria Chimica e Farmaceutica2.48B
Amplifon2.41B
DiaSorin1.22B
Safilo Group998.89M
EL.En.579.71M
Svas Biosana134.95M
Pharmanutra122.25M
Philogen84.66M
Revenue Rankings